达安基因(002030) - 2015年1月20日调研活动附件

Group 1 - Company representatives, including securities affairs representative Zeng Yuting and board secretary Zhang Bin, participated in a meeting with researchers from Guangzhou Guangzheng Hengsheng Securities Co., Ltd., Everbright Securities Co., Ltd., and Southern Fund Management Co., Ltd. [3][4]